Challenges to the Economic Evaluation of New Biotechnological Interventions in Healthcare

Author： Mason J.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.16, Iss.2, 1999-08, pp. : 119-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Future Challenges for the Economic Evaluation of Healthcare: Patient Preferences, Risk Attitudes and Beyond

By Bridges John F.P.  

PharmacoEconomics, Vol. 23, Iss. 4, 2005-01 ,pp. : 317-321

Adis International

Access to resources Recommend Favorite

Value of Information and Pricing New Healthcare Interventions

By Willan Andrew R.  

PharmacoEconomics, Vol. 30, Iss. 6, 2012-06 ,pp. : 447-459

Adis International

Access to resources Recommend Favorite

Methods of Economic Evaluation for the German Statutory Healthcare System

By Caro J. Jaime  

PharmacoEconomics, Vol. 27, Iss. 3, 2009-01 ,pp. : 263-264

Adis International

Access to resources Recommend Favorite

On Individual Preferences and Aggregation in Economic Evaluation in Healthcare

By Liljas B.   Lindgren B.  

PharmacoEconomics, Vol. 19, Iss. 4, 2001-04 ,pp. : 323-335

Adis International

Access to resources Recommend Favorite

Methods of Economic Evaluation for the German Statutory Healthcare System

By Mittendorf Thomas  

PharmacoEconomics, Vol. 27, Iss. 3, 2009-01 ,pp. : 265-265

Adis International

Access to resources Recommend Favorite